February 28th 2013
- The Dorchester, London
In its 19th year, The Pharma Summit, has become established as a major industry event for senior pharma executives in strategic roles. This year's event will be held at The Dorchester in London and will bring together senior figures from across the pharma industry to debate the future of this critical sector.
Inventing and making drugs has always been the lifeblood of the pharma industry. But the current way of doing this is no longer feasible.
Should pharma cut its losses and get out of R&D, or does it still have a role to play in medical research?
There are some serious challenges out there for companies that go down this route. But also some fantastic opportunities.
And at The Pharma Summit, we will focus on the opportunities – come and find out how your organisation can be part of a thriving, research-led pharma industry.
High-level speakers joining us in 2013 include:
- Charlotte Howard, Healthcare Correspondent, The Economist
- Severin Schwan, Chief Executive Officer, Roche
- Ben Goldacre, Doctor, writer and author of 'Bad' Science and 'Bad Pharma'
- Paul Stoffels, MD, Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson
Platinum Sponsor
ADVERTISEMENT
 |
| 08.00 | REGISTRATION AND REFRESHMENTS |
| 09.05 | CHAIR'S INTRODUCTION Charlotte Howard, Healthcare Correspondent, The Economist |
| 09.15 | OPENING KEYNOTE ADDRESS: After the patent cliff - a big pharma perspective Severin Schwan, Chief Executive Officer, Roche Group |
| 09.45 | Pharma and the investor community |
| 10.45 | NETWORKING AND REFRESHMENT BREAK |
| 11.15 | New collaboration models: The R&D department of the future |
| 12.15 | Open innovation - the next frontier in R&D Richard Barker, Director, CASMI (Centre for the Advancement of Sustainable Medical Innovation) Roch Doliveux, Chief Executive Officer and Chairman of the Executive Committee, UCB Paul Stoffels, Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson Anders Gersel Pedersen, Executive Vice-president, Research and Development, Lundbeck |
| 13.10 | LUNCH |
| 14.10 | KEYNOTE ADDRESS: Tomorrow's Biotech David Solomon, President and Chief Executive Officer, Zealand Pharma |
| 14.35 | Paying for it: Pharma in an age of austerity Briggs Morrison, Executive Vice-president, Global Medicines Development, AstraZeneca |
| 15.00 | NETWORKING AND REFRESHMENT BREAK |
15.20
15.45 | Pharma on trial - building a new image Keynote address: Ben Goldacre, Writer, Broadcaster and Medical Doctor Panel discussion: Jane Griffiths, Group Company Chairman, Janssen Europe, Middle East and Africa, Johnson & Johnson Paul Tunnah, Chief Executive Officer and Founder, pharmaphorum |
| 16.25 | CLOSING KEYNOTE ADDRESS: Creating tomorrow's thriving life sciences industry John Castellani, President and Chief Executive Officer, Pharmaceutical Research and Manufacturers of America (PhRMA) |
| 16.50 | CHAIR'S CLOSING REMARKS Charlotte Howard, Healthcare Correspondent, The Economist |
| 17.00 | CLOSE OF SUMMIT |
The Pharma Summit 2013 will be held on February 28th 2013 at The Dorchester, Park Lane, Mayfair, London, W1K 1QA
Platinum Sponsor
ADVERTISEMENT
|
Charlotte Howard, Healthcare Correspondent, The Economist
Charlotte Howard covers the business of health care, including the pharmaceutical industry, medical devices, hospitals and insurers.
Ben Goldacre, Writer, Broadcaster, and Medical Doctor
Ben Goldacre is an award-winning writer, broadcaster and medical doctor who specialises in unpicking scientific claims made by scaremongering journalists, government reports, pharmaceutical corporations, PR companies and quacks.
John Castellani, President and Chief Executive Officer, Pharmaceutical Research and Manufacturers of America (PhRMA)
In his current position, John Castellani's role involves representing America’s leading biopharmaceutical research companies.
Kate Bingham, Managing Partner, SV Life Sciences Advisers (SVLS)
Kate Bingham joined SVLS in 1991. Kate serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany.
Michel Goldman, Executive Director, Innovative Medicines Initiative (IMI)
Michel Goldman currently builds and promotes networks of innovation, in close collaboration with all stakeholders involved in pharmaceutical R&D.
Liz Shanahan, Global Head of Healthcare and Life Sciences, FTI Consulting
Liz Shanahan has nearly two decades of experience in healthcare and life science’s, advising many of the world’s leading healthcare companies, providers and Non-Government Organizations.
Jane Griffiths, Company Group Chairman, Janssen Europe, Middle East and Africa, Johnson & Johnson
As the first female Company Group Chairman of Janssen in EMEA, Jane Griffiths is responsible for business across the entire region.
Severin Schwan, Chief Executive Officer, Roche Group
Severin Schwan has been in his current position since March 2008. For two years prior to this, he was Chief Executive Officer of Diagnostics, the Roche Group’s global diagnostics business.
Richard Barker, Director, CASMI (Centre for the Advancement of Sustainable Medical Innovation)
Richard Barker’s 25 year business career in healthcare has spanned biopharmaceuticals, diagnostics and medical informatics – both in the USA and Europe.
Klaus Wilgenbus, Corporate Senior Vice-president, Boehringer Ingelheim
Klaus Wilgenbus heads Business Development and Licensing and Strategy for Boehringer Ingelheim’s (BI) world-wide ethical pharmaceutical business in Ingelheim, Germany.
Paul Stoffels, Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson
Paul Stoffels is responsible for research and development, business development and global strategy and innovation.
Roch Doliveux, Chief Executive Officer and Chairman of the Executive Committee, UCB
Roch Doliveux has been UCB’s Chief Executive Officer and Chairman of the Executive Committee for the past eight years. He joined UCB in October 2003 as Head of UCB’s Pharmaceutical business and Deputy Chairman of the Executive Committee.
Paul Tunnah, Chief Executive Officer and Founder, pharmaphorum
Just over three years ago Paul Tunnah launched pharmaphorum media, providing digital content marketing and communications solutions for the pharma sector and managing www.pharmaphorum.com.
Edwin Moses, Chief Executive Officer and Chairman of the Board, Ablynx
Edwin Moses has been with Ablynx since 2004 and is also Chairman of Lectus Therapeutics Ltd (UK), the Capricorn Health-tech Fund (Belgium) and a member of the Board of Directors of the European Biopharmaceutical Enterprises.
Anders Gersel Pedersen, Executive Vice-president, Research and Development, Lundbeck
Anders Gersel Pedersen joined Lundbeck in 2000, initially as Vice-president of International Clinical Research. Three years later, Mr Pederson was appointed Senior Vice-president of Drug Development and in 2008 joined the Board of Directors.
Briggs Morrison, Executive Vice-president, Global Medicines Development, AstraZeneca
Briggs Morrison leads AstraZeneca’s global late stage development organisation for both small molecules and biologics and is a member of the Senior Executive Team.
Clive Stanway, Chief Scientific Officer, Cancer Research Technology
Clive Stanway is responsible for the external scientific profile of Cancer Research Technology (CRT) as well as the strategic analysis and development of the CRT project portfolio.
David Solomon, President and Chief Executive Officer, Zealand Pharma
David Solomon joined Zealand Pharma in September 2008 from a position as Chief Operating Officer of Vital Sensors. From 2003 to 2006, Dr Solomon led healthcare investing at Carrot Capital Healthcare Ventures.
Platinum Sponsor
ADVERTISEMENT
|
Platinum Sponsor
ADVERTISEMENT
|
Platinum sponsor:
|
Platinum Sponsor
ADVERTISEMENT
|
Exhibitor
Catenion is a management consulting firm devoted to helping pharmaceutical and medical products companies create more innovative and effective strategies and organisations and significantly increase their returns on R&D. We greatly improve how our clients assess the value and risk of their project and product portfolios and how they allocate resources.
|
DHL Supply Chain has been at the forefront of innovative supply chain solutions for the healthcare and life sciences industry for over 25 years. Our broad range of services includes specialist warehousing, packaging services, managed transport, home delivery services, product launch support and clinical trials. These services are provided within state-of-the-art, MHRA-accredited facilities, including temperature-controlled and high-security environments and are run by experts in the healthcare field. |
Platinum Sponsor
ADVERTISEMENT
|
Supporting PR Agency:
|
Supporting Organisations:
|
|
|
Health Imaging Hub – Global Reach, Local Focus |
ABOUTPHARMA AND MEDICAL DEVICES is 10 years from the point of reference for healthcare professionals and the pharmaceutical industry. |
EuropaBio has a board of management made up of representatives of member companies.The board is supported by the EuropaBio secretariat who carry out day to day activities and is managed by a Secretary General. |
Thomson Reuters Life Sciences supports R&D productivity across the Pharma lifecycle with |
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. |
PM360 is the premier, must-read monthly magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. PM360 is the only journal that delivers the full spectrum of practical information necessary for product managers and pharma-marketing professionals to succeed in the complex and highly regulated healthcare environment. PM360 focuses on critical issues: cutting-edge strategy planning and implementation, technological advances, trends, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. |
pharmaphorum media provides digital content marketing and communications solutions for the pharma sector and also manages the industry leading channel www.pharmaphorum.com, a digital podium for communicating thought leadership and innovation within pharma. Ph: +1 760 436 1199 www.pharmacircle.com |
pharmaphorum media provides digital content marketing and communications solutions for the pharma sector and also manages the industry leading channel www.pharmaphorum.com, a digital podium for communicating thought leadership and innovation within pharma. |
Platinum Sponsor
ADVERTISEMENT
|
The Dorchester
The Dorchester occupies the most prestigious acre and a half of real estate in the world; in the heart of London overlooking the glorious green expanse of Hyde Park. The Dorchester embodies the highest service values, whilst its design and character exude 1930s glamour with a contemporary edge.
Address
The Dorchester
Park Lane
Mayfair
London
W1K 1QA
Tel: +44 207 629 8888
Heathrow Airport
- 45 minutes by car
- 50 minutes by the Piccadilly underground line
- 15 minutes by Express Link from Paddington Station (Paddington Station is 10 minutes by car)
Gatwick Airport
- 30 minutes by Gatwick Express from Victoria Station (Victoria Station is 5 minutes by car)
St. Pancras Eurostar Terminal
- 10 minutes by car
The City
- 20 minutes by car
Nearest London Underground Stations
- Marble Arch
- Hyde Park Corner
- Green Park
Address
The Dorchester
Park Lane
London
United Kingdom
Javascript is required to view this map.
Platinum Sponsor
ADVERTISEMENT
|
| FEES |
|
| BOOKING OPTIONS |
1. ONLINE Please note you will be directed to an external site to complete your booking. |
2. BY POST OR FAX Please download the registration form and return by: |
3. BY PHONE Please call customer services on +44 (0)207 576 8118 |
Platinum Sponsor
ADVERTISEMENT
|
Inventing and making drugs has always been the lifeblood of the pharma industry. But the current way of doing this is no longer feasible. Should pharma cut its losses and get out of R&D, or does it still have a role to play in medical research? Join us and our experts to debate the REAL BUSINESS of pharma.
Now in its 18th year, our annual Pharma Summit will this year look at the emerging healthcare models and discuss what part pharma will play over the next five to ten years.
How can pharma rebuild its image and position itself as a key industry in tomorrow’s marketplace? Join the debate where top pharma players will share their thoughts on the out look for the pharma industry in the long term and discuss the business models for future success.
Technology, reform and innovation are driving significant changes in how healthcare is delivered. The pharma industry will play a crucial role in shaping this, but will need to innovate to stay ahead. Join us at The Pharma Summit to understand how firms can take advantage of these developments.
Platinum Sponsor
ADVERTISEMENT
|
Send to friend
